Comparing Two Injection Sites of Local Anesthetic for Hand Surgery

Not Applicable

Completed

• Conditions: Wrist Injury; Hand Injury; Finger Injury
• Interventions: Procedure: 0.5% bupivacaine injected in the forearm; Procedure: 20-30ml of 0.5% bupivacaine.

• Registration Number: NCT02112006
• Lead Sponsor: Jose Soberon, MD

Brief Summary

The purpose of this study is to compare two different injection sites for local anesthesia in patients having hand surgery. The hypothesis is that subjects receiving injections around the three nerves of the forearm will provide faster pain control and greater patient satisfaction than patients having one injection closer to the shoulder.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-04
• Study First Submitted: 2014-04-08
• Study First Submitted QC: 2014-04-09
• Study First Posted: 2014-04-11
• Status Verified: 2015-10
• Primary Completion: 2016-03
• Study Completion: 2016-03
• Last Update Submitted: 2016-03-21
• Last Update Posted: 2016-03-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Patients ≥ 18 years of age undergoing unilateral hand, wrist, or finger surgery
• Ability to understand and provide informed consent
• American Society of Anesthesiologists (ASA) status I-III

Exclusion Criteria

• Patient refusal or inability to provide informed consent
• True allergy, not sensitivity, to any of the following substances: Local Anesthetics, Midazolam, Fentanyl, Hydromorphone, Propofol
• Pregnancy
• Severe hepatic impairment
• Evidence of infection at or near the proposed needle insertion site
• Any sensorimotor deficit of the ipsilateral upper extremity, whether acute or chronic, as determined by the PI and designee
• Pulmonary disease of any kind that is uncontrolled or severe in nature
• Chronic pain patients, defined as someone diagnosed with chronic pain or a chronic pain condition, under the care of a chronic pain physician, or taking oral/intravenous narcotics consistently for 30 days prior to surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
distal injection	0.5% bupivacaine injected in the forearm	0.5% bupivacaine injected in the forearm
proximal injection	20-30ml of 0.5% bupivacaine.	20-30ml of 0.5% bupivacaine

Primary Outcome Measures

Name	Time	Method
success of block	up to 30 minutes after injection	number of participants that needed additional anesthesia

Secondary Outcome Measures

Name	Time	Method
pain scores	up to 10 days after surgery	change in pain scores

Trial Locations

Locations (1)

Ochsner Clinic Foundation; 🇺🇸 New Orleans, Louisiana, United States